Instadose Pharma Corp.
Income Statement
Last updated:
Income statement is a financial statement that shows how profitable a business was over a given reporting period presenting its revenue, expenses or net income.
Profit Margin
| 2016 | 0 | -1.94K | |
|---|---|---|---|
| 2019 | 0 | -38.58K | |
| 2022 | 0 | 0 |
INSD Income Statement (2017 – 2023)
| 2023 | 2020 | 2017 | |
|---|---|---|---|
Revenue | |||
Revenue | 0 | 0 | 0 |
Cost of revenue | 0 | 0 | 0 |
Gross profit | 0 | 0 | 0 |
Operating exp. | |||
Research and development | 0 | 0 | 0 |
Selling and marketing | 0 | 0 | 0 |
Total operating expenses | 0 | 30.92K | 1.94K |
Operating income | 0 | -23.27K | -1.94K |
Other income (expenses), net | 0 | 0 | -1 |
Income before tax | 0 | -30.92K | -1.94K |
Income tax expense | 0 | 7.65K | 0 |
Net income | 0 | -38.58K | -1.94K |
Earnings per share | |||
Basic EPS | 0 | -0.00 | -0.00 |
Diluted EPS | 0 | -0.00 | -0.00 |
| Data source |